Cited by

• The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer.

  Ucaryilmaz Metin C, Ozcan G. Ucaryilmaz Metin C, et al. Cancers (Basel). 2022 May 30;14(11):2711. doi: 10.3390/cancers14112711. Cancers (Basel). 2022. PMID: 35681691 Free PMC article. Review.
• Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.

  Deben C, Deschoolmeester V, De Waele J, Jacobs J, Van den Bossche J, Wouters A, Peeters M, Rolfo C, Smits E, Lardon F, Pauwels P. Deben C, et al. Cancers (Basel). 2018 Apr 21;10(4):126. doi: 10.3390/cancers10040126. Cancers (Basel). 2018. PMID: 29690507 Free PMC article.
• Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy.

  Hong BJ, Kim J, Jeong H, Bok S, Kim YE, Ahn GO. Hong BJ, et al. Radiat Oncol J. 2016 Dec;34(4):239-249. doi: 10.3857/roj.2016.02012. Epub 2016 Dec 28. Radiat Oncol J. 2016. PMID: 28030900 Free PMC article. Review.
• Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition.

  Scortegagna M, Martin RJ, Kladney RD, Neumann RG, Arbeit JM. Scortegagna M, et al. Cancer Res. 2009 Mar 15;69(6):2638-46. doi: 10.1158/0008-5472.CAN-08-3643. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276359 Free PMC article.
• HIF-transcribed p53 chaperones HIF-1α.

  Madan E, Parker TM, Pelham CJ, Palma AM, Peixoto ML, Nagane M, Chandaria A, Tomás AR, Canas-Marques R, Henriques V, Galzerano A, Cabral-Teixeira J, Selvendiran K, Kuppusamy P, Carvalho C, Beltran A, Moreno E, Pati UK, Gogna R. Madan E, et al. Nucleic Acids Res. 2019 Nov 4;47(19):10212-10234. doi: 10.1093/nar/gkz766. Nucleic Acids Res. 2019. PMID: 31538203 Free PMC article.